ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,246.68
0.48%
US Tech 100
17,842.00
0.67%
다우존스 지수
39,558.11
0.32%
Bitcoin
61,702.41
-1.91%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. VBI Vaccines Inc (VBIV)

  7. VBI Vaccines Inc (VBIV) 뉴스

VBIV

VBI Vaccines (VBIV)

VBI Vaccines Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VBIV
일자시간출처헤드라인심볼기업
2024/04/1621:00Business WireVBI Vaccines Reports Full Year 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
2024/04/1205:05Business WireVBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
2024/04/1003:45Business WireVBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
2024/04/0321:00Business WireVBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent GlioblastomaNASDAQ:VBIVVBI Vaccines Inc
2024/04/0221:00Business WireVBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine PlatformNASDAQ:VBIVVBI Vaccines Inc
2024/02/1422:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2024/02/1421:00Business WireVBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii BiosciencesNASDAQ:VBIVVBI Vaccines Inc
2024/02/0706:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2024/01/2406:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2024/01/1206:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/12/2706:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/12/1306:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/11/3006:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/11/2022:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/11/2022:00Business WireVBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:VBIVVBI Vaccines Inc
2023/11/1506:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/11/1506:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
2023/11/1506:05Business WireVBI Vaccines Reports Third Quarter 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
2023/11/0406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/10/2621:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/10/2621:00Business WireVBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine ProgramNASDAQ:VBIVVBI Vaccines Inc
2023/09/2720:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/09/2720:30Business WireVBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of ConcernNASDAQ:VBIVVBI Vaccines Inc
2023/09/0721:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/09/0721:00Business WireVBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBMNASDAQ:VBIVVBI Vaccines Inc
2023/09/0622:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/09/0621:00Business WireVBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis BNASDAQ:VBIVVBI Vaccines Inc
2023/08/1421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
2023/08/1421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
2023/08/1421:00Business WireVBI Vaccines Reports Second Quarter 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
 검색 관련기사 보기:NASDAQ:VBIV

최근 히스토리

AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
NYSE
AXP
American Express
USOTC
RHHBY
Roche (QX)
NYSE
BAC
Bank of America
CCOM
US30
US 30
NASDAQ
TSLA
Tesla
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
NYSE
XOM
Exxon Mobil
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유